EVOGENEEVOGENEEVOGENE

EVOGENE

No trades
See on Supercharts
Market capitalization
‪130.19 M‬ILS
‪−86.70 M‬ILS
‪20.48 M‬ILS
‪49.71 M‬
Beta (1Y)
1.98

About EVOGENE

CEO
Ofer Haviv
Headquarters
Rehovot
Employees (FY)
142
Founded
1999
ISIN
IL0011050551
FIGI
BBG000PPN4T1
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EVGN is 259.70 ILA — it has decreased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange EVOGENE stocks are traded under the ticker EVGN.
EVOGENE is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for EVOGENE has a max estimate of 10.80 ILA and a min estimate of 6.66 ILA.
EVGN earnings for the last quarter are −0.31 ILA whereas the estimation was −0.60 ILA which accounts for 48.94% surprise. Estimated earnings for the next quarter are −0.51 ILA. See more details about EVOGENE earnings.
EVOGENE revenue for the last quarter amounts to ‪14.39 M‬ ILA despite the estimated figure of ‪4.57 M‬ ILA. In the next quarter revenue is expected to reach ‪1.72 M‬ ILA.
Yes, you can track EVOGENE financials in yearly and quarterly reports right on TradingView.
Like other stocks, EVGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVOGENE stock right from TradingView charts — choose your broker and connect to your account.
EVGN reached its all-time high on Jan 1, 2014 with the price of 6995.00 ILA, and its all-time low was 189.30 ILA and was reached on Oct 15, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 142.00 employees. See our rating of the largest employees — is EVOGENE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EVOGENE EBITDA is ‪−86.77 M‬ ILS, and current EBITDA margin is −421.61%. See more stats in EVOGENE financial statements.